Navigation Links
Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Date:1/4/2012

three months of follow up, for which historical data are available, the percentage of patients gaining three or more lines was 50-55% in both dosing cohorts. These values are higher than historical data reported in two different published clinical studies exploring the natural course of the disease where only 39 or 20% of patients, respectively, gained 3 or more lines at 3 months after disease onset(1). In the latter case, the advantages of treatment with QPI-1007 were strongly significant. Furthermore, at 1 month after the administration of QPI-1007, patients gained on average 13 and 16 letters in the two dose groups. At 3 months, average letter gain was 14 in both groups and none of the patients lost vision compared to screening data.  A change of 15 letters is considered to be a substantial improvement in visual acuity. Evaluation of these patients is ongoing, with additional assessments planned at six- and 12-months post-injection.

"We are very encouraged by these interim clinical data. The data suggest that QPI-1007 may improve visual acuity in NAION patients.  Based on the interim data from this clinical study, and from our positive results from preclinical studies in three different models of optic neuropathy, including a model of glaucoma, we believe QPI-1007 may protect neurons in the retina and optic nerve in NAION and in other types of optic neuropathy, the most common of which is glaucoma," said Dr. Daniel Zurr, Quark's Chief Executive Officer. "QPI-1007 represents Quark's first drug with proprietary RNAi structure, and we believe these interim results support our position as a world leader in the discovery and development of RNAi-based therapeutics."

About NAION

Non-arteritic ischemic optic neuropathy (NAION) is the most common cause of sudden optic nerve-related vision loss. NAION is an acute ischemic disorder believed to be caused by insufficient arterial blood flow to the optic nerve via the posterior c
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Cynosure, Inc. ... light-based aesthetic treatments for non-invasive and minimally invasive applications, today ... President, Chief Operating Officer and Chief Financial Officer Timothy ... 1, 2014.  Baker, 53, will continue to serve as CFO ... Davin , who remains Chairman and Chief Executive Officer. ...
(Date:7/30/2014)... 30, 2014  Packaging Coordinators, Inc. (PCI) is pleased ... acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma is ... the United Kingdom and operates ... and Tokyo , Japan. Penn Pharma ... and Commercial dosage form manufacturing, as well as Clinical ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment ... have been awarded a Department of Defense (US Army) ... to supply a mobile MRI diagnostic machine and technical ... Business (WOSB) through the Small Business Administration (SBA), Medical ... the field with the latest medical diagnostic equipment. The ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... Reportlinker.com announces that a new market research ... Global Computer Assisted Surgical (CAS) Systems ... This report analyzes the worldwide markets ... Million by the following Product Segments: Surgical Planners ...
... YORK, Feb. 24, 2011 Reportlinker.com announces that a ... Global Drug-Eluting Stents Industry ... report analyzes the worldwide markets for Drug-Eluting Stents in ... the US, Japan, Europe, and Rest of World. Annual ...
Cached Medicine Technology:Reportlinker Adds Global Computer Assisted Surgical (CAS) Systems Industry 2Reportlinker Adds Global Drug-Eluting Stents Industry 2
(Date:7/30/2014)... Bentonville, AR (PRWEB) July 30, 2014 ... providing their patients with free oral cancer screenings. Using ... team will work to detect the disease in its ... the lips, tongue, cheek, mouth, sinuses, throat and other ... National Cancer Institute’s Surveillance, Epidemiology, and Ends Results (SEER) ...
(Date:7/30/2014)... Falls Church, VA (PRWEB) July 30, 2014 ... Investigations , Understanding Advanced Critical Thinking Skills and ... , **Presented by Immel Resources and FDAnews**, Sept. ... , CAPA has been the #1 reason for ... plan makes it clear: Developing a successful CAPA ...
(Date:7/30/2014)... Ann Arbor, MI (PRWEB) July 30, 2014 ... Madrid vs. Manchester United Tickets in Ann Arbor, MI on ... in the world of international football will be competing on American ... at “The Big House,” in Ann Arbor, Mich. The home of ... venue is one of the most prestigious in all of American ...
(Date:7/30/2014)... Reinberg HealthDay Reporter WEDNESDAY, ... United States, at least 2,000 Americans die from extreme heat ... Heat waves, heat stroke or sun stroke caused nearly one-third ... 2010, according to the U.S. Centers for Disease Control and ... of body heat -- accounted for 63 percent of those ...
(Date:7/30/2014)... 2014 Volunteers from the Church of ... abuse this summer with massive distribution of Truth ... find these volunteers on Strøget, the famous Copenhagen walking ... its shopping and its ambiance, some quarter of a ... summer day. , These activities are part of ...
Breaking Medicine News(10 mins):Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 4Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 2Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 3Health News:Manchester United vs. Real Madrid Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for Real Madrid vs. ManU Guinness International Champions Cup Match 4Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 3
... - Advance directive forms that attempt to steer users toward ... a bad name, Aging with Dignity President says - ... Malley, President of the national non-profit organization Aging with Dignity, said ... Veterans Affairs current advance care planning tool, "Your Life, Your Choices." ...
... Ky., Aug. 19 VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) ... the announcement made earlier this week on August 17th regarding the ... fees as well as VHGI,s agreement to revise the terms of ... August 17th release please go to http://www.virtu a ...
... safely and painlessly, researchers say , WEDNESDAY, Aug. 19 ... may someday offer a painless alternative to hypodermic ... The technique could make flu shots a thing of ... safer and more effective, the researchers said. Their work ...
... tiny nanorods of zinc oxide has been developed for the ... in the current issue of the International Journal of ... in medical and for other applications. Zinc oxide has ... nanometers in diameter. In such as nanoscopic form, it can ...
... Scientists from the U.S. Department of Energy,s (DOE) Argonne ... Center have developed a way to target brain ... soft biological material. Thousands of people die from ... resistant to conventional therapies. This nano-bio technology may eventually ...
... , , White paper outlines ... , , PLYMOUTH MEETING, Pa., Aug. 19 ... of medical supplies, such as pricey orthopedic implants and cardiovascular devices, ... With operating costs increasing and margins from both operations and pooled ...
Cached Medicine News:Health News:Veterans Deserve Respect, Not Sly Coercion in Advance Care Planning, Says Aging with Dignity President 2Health News:VirtualHealth Technologies Files 8k Related to the August 17th Announcement of Private Access Payment and Document Modification 2Health News:VirtualHealth Technologies Files 8k Related to the August 17th Announcement of Private Access Payment and Document Modification 3Health News:Patch 'Shots' May Someday Replace Injections 2Health News:A safe approach to nanotechnology 2Health News:Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials 2Health News:Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 2Health News:Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 3
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... operate in a wide variety of applications. • ... manifold can be freely rotated against the handle ... at an optimum angle towards the microtiter plate. ... use of most common pipette tips, and provides ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... Finnpipette Focus multichannel ... dispensing of reagents into ... for 0.1-10 l volumes. ... of Finnpipette Focus multichannels, ...
Medicine Products: